<?xml version="1.0" encoding="UTF-8"?>
<p>At the same time, non-toxic antiviral drugs are indispensable for treatment, and potentially prophylaxis, of infection in inborn and acquired immunodeficiency syndromes in which the latent genome has been reactivated. Reactivation in immunosuppressed individuals results in abundant viral replication that has the potential for genesis of B-cell lymphomas because of EBVâ€™s ability to immortalize B-cells. In the immunocompetent, there is initially runaway B-cell proliferation, but it is normally checked by efficient T-cell responses.</p>
